Active, not recruiting
Study of Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Obinutuzumab in Participants With Chronic Lymphocytic Leukemia (CLL)
NCT06073821
- Conditions
- CLL, Chronic Disease, Disease Attributes, +14 more
- Locations
-
- Alaska Oncology and Hematology, Llc Anchorage, Alaska, United States
- City of Hope National Medical Center Duarte, California, United States
- University of California San Diego (Ucsd) Moores Cancer Center La Jolla, California, United States
- Valkyrie Clinical Trials Los Angeles, California, United States